Raccah D, Gallice P, Pouget J, Vague P
Department of Diabetes, University Hospital La Timone, Marseille, France.
Diabete Metab. 1992 May-Jun;18(3):236-41.
The development of diabetic complications does not depend entirely on diabetes duration and control. Predisposing and aggravating factors, either constitutional or environmental, seem to play a role. We have previously observed that polyneuropathy is more frequent, of earlier onset, and more severe among North African insulin-dependent diabetic patients than among Europeans matched for sex, duration and control of diabetes. The Na/K-ATPase activity displays sex and ethnic differences and a dysfunction of this enzyme is probably involved in the pathogenesis of diabetic neuropathy. We have therefore postulated that the predisposition of some diabetic patients to develop a polyneuropathy could be related to a low Na/K-ATPase activity.
Red cell membrane Na/K-ATPase activity was studied in European men presenting with insulin-dependent diabetes mellitus for more than 15 years. 10 patients with neuropathy were matched to 10 patients void of neuropathy on duration of diabetes and HbA1c values. Thirteen healthy European men and 13 North African men born and living in France were also studied.
Na/K-ATPase activity was lower in patients with neuropathy (200 +/- 31 vs 289 +/- 42 nmol Pi.mg protein-1.h-1 mean +/- SD; p less than 0.05). When compared to that of 13 European healthy men, Na/K-ATPase activity was lower in the whole group of diabetic patients but appeared to be in the normal range for patients without neuropathy and decreased in those with neuropathy. The 13 North African healthy men had lower values than the European healthy men (227 +/- 46 vs 298 +/- 60 nmol Pi.mg protein -1.h-1, p less than 0.05).
Red cell membrane Na/K-ATPase activity is low in insulin dependent patients with neuropathy compared to those without neuropathy. This finding probably reflects a constitutional difference. This association could be explained if red cell and nerve membrane Na/K-ATPase abnormalities behave similarly according to glycaemic control in diabetic subjects. It is suggested that the predisposition to neuropathy of North African insulin-dependent diabetic patients may be related to lower Na/K-ATPase activity. A high level of activity of this enzyme may protect from diabetic neuropathy. This enzyme activity could be a marker of predisposition towards diabetic polyneuropathy.
糖尿病并发症的发生并不完全取决于糖尿病病程和控制情况。遗传和加重因素,无论是体质性的还是环境性的,似乎都起作用。我们之前观察到,在性别、病程和糖尿病控制情况相匹配的情况下,北非胰岛素依赖型糖尿病患者的多发性神经病变比欧洲患者更常见、发病更早且更严重。钠钾ATP酶活性存在性别和种族差异,该酶功能异常可能参与了糖尿病神经病变的发病机制。因此,我们推测一些糖尿病患者易患多发性神经病变可能与钠钾ATP酶活性降低有关。
对患有胰岛素依赖型糖尿病超过15年的欧洲男性的红细胞膜钠钾ATP酶活性进行研究。根据糖尿病病程和糖化血红蛋白值,将10例有神经病变的患者与10例无神经病变的患者进行匹配。还研究了13名健康的欧洲男性以及13名在法国出生并生活的北非男性。
有神经病变的患者钠钾ATP酶活性较低(分别为200±31与289±42 nmol Pi·mg蛋白-1·h-1,均值±标准差;p<0.05)。与13名健康欧洲男性相比,糖尿病患者总体的钠钾ATP酶活性较低,但无神经病变的患者该酶活性似乎在正常范围内,而有神经病变的患者则降低。13名北非健康男性的值低于欧洲健康男性(分别为227±46与298±60 nmol Pi·mg蛋白-1·h-1,p<0.05)。
与无神经病变的胰岛素依赖型患者相比,有神经病变的患者红细胞膜钠钾ATP酶活性较低。这一发现可能反映了体质差异。如果糖尿病患者中红细胞和神经膜钠钾ATP酶异常根据血糖控制情况表现相似,那么这种关联就可以得到解释。提示北非胰岛素依赖型糖尿病患者易患神经病变可能与较低的钠钾ATP酶活性有关。该酶的高活性水平可能对糖尿病神经病变有保护作用。这种酶活性可能是易患糖尿病多发性神经病变的一个标志物。